» pharma stock News

pharma stock

Navratna SIP by Anil Singhvi: This pharma stock can give 82% return - Check targets | Stock to BUY for Long Term

Navratna SIP by Anil Singhvi: This pharma stock can give 82% return - Check targets | Stock to BUY for Long Term

Fri, Oct 04, 2024

Navratna SIP By Anil Singhvi, Stock To Buy For Long Term: The stock market has been quite volatile and Sensex dropped 354.67 points to 82,142.43 in early trade and Nifty declined 114.1 points to 25,136.

More >

215% return in 2 years: Buy this pharma stocks before Q1FY25 results - Check target price by Anil Singhvi

215% return in 2 years: Buy this pharma stocks before Q1FY25 results - Check target price by Anil Singhvi

Thu, Jul 04, 2024

Zydus Lifesciences Share Price Target: Anil Singhvi has advised investors to buy this pharma stock when it is available in the range of Rs 1,100. 

More >

Why stock of this large-cap pharma firm rose nearly 6% in today's trade; know share price target

Why stock of this large-cap pharma firm rose nearly 6% in today's trade; know share price target

Thu, Jul 04, 2024

Lupin shares saw significant rise on Thursday after brokerage double uprgraded it to 'add'. It has given 12-month target of Rs 1,805 for the stock.   

More >

TRENDING NOW

Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000

Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000

Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations

Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations

Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here

Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here

Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others

Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others

New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets

New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets

PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?

PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?

Power of Compounding: How many years it will take to reach Rs 2 crore corpus if your monthly SIP is Rs 3,000, Rs 4,000, or Rs 5,000

Power of Compounding: How many years it will take to reach Rs 2 crore corpus if your monthly SIP is Rs 3,000, Rs 4,000, or Rs 5,000

Senior Citizen FD: SBI 3-year FD vs PNB 3-year FD vs HDFC Bank 3-year FD; which FD will give highest return on Rs 5 lakh investment

Senior Citizen FD: SBI 3-year FD vs PNB 3-year FD vs HDFC Bank 3-year FD; which FD will give highest return on Rs 5 lakh investment

Sun Pharma inks licensing pact with Aclaris Therapeutics

Sun Pharma inks licensing pact with Aclaris Therapeutics

Wed, Dec 06, 2023

Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases.

More >

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x